Innovid (NYSE:CTV) Downgraded by JMP Securities to “Market Perform”

JMP Securities downgraded shares of Innovid (NYSE:CTVFree Report) from an outperform rating to a market perform rating in a report issued on Thursday, Marketbeat Ratings reports.

Separately, Needham & Company LLC reaffirmed a “buy” rating and set a $3.00 target price on shares of Innovid in a report on Wednesday, November 13th.

Check Out Our Latest Stock Report on CTV

Innovid Trading Up 86.3 %

Innovid stock opened at $3.02 on Thursday. The firm’s 50 day simple moving average is $1.86 and its 200 day simple moving average is $1.89. The firm has a market capitalization of $441.78 million, a PE ratio of -33.53 and a beta of 3.08. Innovid has a 1-year low of $1.25 and a 1-year high of $3.05.

Hedge Funds Weigh In On Innovid

Institutional investors have recently made changes to their positions in the stock. FMR LLC increased its holdings in shares of Innovid by 590.2% in the 3rd quarter. FMR LLC now owns 15,413 shares of the company’s stock worth $28,000 after buying an additional 13,180 shares during the last quarter. Miller Investment Management LP bought a new position in shares of Innovid in the 3rd quarter worth $36,000. SG Americas Securities LLC bought a new position in shares of Innovid in the 1st quarter worth $56,000. Lazard Asset Management LLC bought a new position in shares of Innovid during the 1st quarter valued at $58,000. Finally, American Century Companies Inc. bought a new position in shares of Innovid during the 2nd quarter valued at $61,000. Institutional investors own 25.46% of the company’s stock.

About Innovid

(Get Free Report)

Innovid Corp. operates an independent software platform that provides ad serving, measurement, and creative services. It offers advertising services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV, and desktop TV environments to advertisers, publishers, and media agencies.

Recommended Stories

Receive News & Ratings for Innovid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovid and related companies with MarketBeat.com's FREE daily email newsletter.